Golimumab

Details

Files

Generic Name:

Golimumab

Project Status:

Complete

Therapeutic Area:

Arthritis, psoriatic

Manufacturer:

Centocor Inc.

Brand Name:

Simponi

Project Line:

Reimbursement Review

Project Number:

SR0195-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Arthritis, psoriatic

Recommendation Type:

List in a similar manner

Final Recommendation:

March 17, 2010

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : September 3, 2009